The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
BLAC
Bellevue Life Sciences Acquisition Corp. Common Stock
Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) Annual Income Statement (USD)
BLAC Quarterly Financials (USD)
Frequently Asked Questions About Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) Stock
Bellevue Life Sciences Acquisition Corp. Common Stock's (BLAC) last reported annual revenue was N/A.
Bellevue Life Sciences Acquisition Corp. Common Stock's (BLAC) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) is not profitable as of its last reported annual financials.
The net profit margin for Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) from its laster reported year is N/A
The return on equity (ROE) for Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) from its last reported annual financials is : 0.00%
The return on assets (ROA) for Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) from its last reported annual financials is : -2.98%
The return on invested capital (ROIC) for Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) from its last reported annual financials is : -14.08%
The Debt to Equity ratio for Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) from its last reported annual financials is : 0.00%
The dividend yield for Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) from its laster reported year is 0.00%
Bellevue Life Sciences Acquisition Corp. Common Stock's(BLAC) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BLAC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
